Pharmacist, Research Disease Group

WeekdayDoc's proprietary algorithm rates Pharmacist, Research Disease Group at Dana-Farber Cancer Institute a 2.0 out of 10 for work-life balance — classified as below average. This places the position in the average range of all Pharmacy pharmacist listings evaluated on our platform.

Candidates should carefully assess workload expectations and scheduling demands before applying.

This Pharmacy position at Dana-Farber Cancer Institute is open to pharmacist candidates.

Pharmacists are expanding beyond traditional dispensing roles into clinical consulting, medication management, and remote pharmacy services.

Dana-Farber Cancer Institute lists compensation for this pharmacist position at $124k to $160k annually.

This employer qualifies for Public Service Loan Forgiveness (PSLF). Eligible clinicians can have their remaining federal student loan balance forgiven after 120 qualifying monthly payments (10 years). For physicians and advanced practice providers carrying significant educational debt, PSLF eligibility can represent hundreds of thousands of dollars in long-term financial benefit.

This position is based in Boston, Massachusetts.

Key skills and qualifications: Protocol Reviews, Protocol Education, Study Drug Supplies, Protocol Development, Protocol Implementation, Compliance, SOP Adherence, Multidisciplinary Collaboration. Candidates with experience in these areas may be especially well-suited for this Pharmacy role.

Core responsibilities: The Research Disease Group Pharmacist II supports patient care research by reviewing protocol proposals, coordinating protocol education, managing study drug supplies, and assisting investigators with protocol development and implementation. Primary duties include completing pharmacy reviews of clin...